11 sept. 2017 - FDA held a Pediatric Advisory Committee meeting to discuss the use of prescription opioid products containing hydrocodone or codeine for the treatment of cough in pediatric patients. The discussion included current practice for the treatment of cough in children and benefit-risk considerations regarding the use of prescription opioid products in pediatric patients.
Ajouté au bande de temps:
Date:
11 sept. 2017
Maintenaint
~ Il y a 8 ans